SC-4289 explained

SC-4289 is a synthetic nonsteroidal estrogen which, along with mytatrienediol (SC-6924; Manvene, Anvene), was developed in the late 1950s as a potential treatment for atherosclerosis in men but was never marketed.[1]

Notes and References

  1. DAVIS FW, SCARBOROUGH WR, MASON RE, SINGEWALD ML, BAKER BM . Experimental hormonal therapy of atherosclerosis: preliminary observations on the effects of two new compounds . Am. J. Med. Sci. . 235 . 1 . 50–9 . 1958 . 13487586 . 10.1097/00000441-195801000-00006. 762067 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "SC-4289".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.